| Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells R Pérez, X Matabosch, A Llebaria, MA Balboa, J Balsinde Journal of lipid research 47 (3), 484-491, 2006 | 207 | 2006 |
| Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase JM Munoz‐Olaya, X Matabosch, C Bedia, M Egido‐Gabás, J Casas, ... ChemMedChem: Chemistry Enabling Drug Discovery 3 (6), 946-953, 2008 | 85 | 2008 |
| Identification of budesonide metabolites in human urine after oral administration X Matabosch, OJ Pozo, C Pérez-Mañá, M Farré, J Marcos, J Segura, ... Analytical and bioanalytical chemistry 404, 325-340, 2012 | 55 | 2012 |
| Detection and characterization of prednisolone metabolites in human urine by LC‐MS/MS X Matabosch, OJ Pozo, C Pérez‐Mañá, E Papaseit, J Segura, R Ventura Journal of Mass Spectrometry 50 (3), 633-642, 2015 | 44 | 2015 |
| Cytotoxicity and acid ceramidase inhibitory activity of 2-substituted aminoethanol amides C Bedia, D Canals, X Matabosch, Y Harrak, J Casas, A Llebaria, ... Chemistry and physics of lipids 156 (1-2), 33-40, 2008 | 44 | 2008 |
| Urinary profile of methylprednisolone and its metabolites after oral and topical administrations X Matabosch, OJ Pozo, N Monfort, C Pérez-Mañá, M Farré, J Marcos, ... The Journal of Steroid Biochemistry and Molecular Biology 138, 214-221, 2013 | 41 | 2013 |
| Discrimination of prohibited oral use from authorized inhaled treatment of budesonide in sports X Matabosch, OJ Pozo, C Pérez-Mañá, M Farré, J Marcos, J Segura, ... Therapeutic drug monitoring 35 (1), 118-128, 2013 | 40 | 2013 |
| Detection and characterization of clostebol sulfate metabolites in Caucasian population G Balcells, OJ Pozo, L Garrostas, A Esquivel, X Matabosch, A Kotronoulas, ... Journal of Chromatography B 1022, 54-63, 2016 | 37 | 2016 |
| Using complementary mass spectrometric approaches for the determination of methylprednisolone metabolites in human urine OJ Pozo, J Marcos, X Matabosch, R Ventura, J Segura Rapid Communications in Mass Spectrometry 26 (5), 541-553, 2012 | 37 | 2012 |
| Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports X Matabosch, OJ Pozo, C Pérez-Mañá, E Papaseit, J Marcos, J Segura, ... The Journal of Steroid Biochemistry and Molecular Biology 145, 94-102, 2015 | 31 | 2015 |
| Detection and characterization of betamethasone metabolites in human urine by LC‐MS/MS X Matabosch, OJ Pozo, N Monfort, C Pérez‐Mañá, M Farré, J Segura, ... Drug Testing and Analysis 7 (8), 663-672, 2015 | 30 | 2015 |
| Detection of stanozolol O‐ and N‐sulfate metabolites and their evaluation as additional markers in doping control G Balcells, X Matabosch, R Ventura Drug testing and analysis 9 (7), 1001-1010, 2017 | 25 | 2017 |
| Additional studies on triamcinolone acetonide use and misuse in sports: elimination profile after intranasal and high-dose intramuscular administrations S Coll, N Monfort, É Alechaga, X Matabosch, C Pérez-Mañá, R Ventura Steroids 151, 108464, 2019 | 20 | 2019 |
| Detection and characterization of triamcinolone acetonide metabolites in human urine by liquid chromatography/tandem mass spectrometry after intramuscular administration X Matabosch, OJ Pozo, E Papaseit, M Farré, J Marcos, J Segura, ... Rapid Communications in Mass Spectrometry 28 (16), 1829-1839, 2014 | 20 | 2014 |
| Elimination profile of triamcinolone hexacetonide and its metabolites in human urine and plasma after a single intra‐articular administration S Coll, X Matabosch, J Llorente‐Onaindia, M Carbó, C Pérez‐Mañá, ... Drug Testing and Analysis 11 (11-12), 1589-1600, 2019 | 18 | 2019 |
| Elimination profiles of betamethasone after different administration routes: evaluation of the reporting level and washout periods to ensure safe therapeutic administrations S Coll, N Monfort, É Alechaga, X Matabosch, C Pérez‐Mañá, R Ventura Drug Testing and Analysis 13 (2), 348-359, 2021 | 17* | 2021 |
| Effect of glucocorticoid administration on the steroid profile S Coll, X Matabosch, L Garrostas, C Perez‐Maña, R Ventura Drug testing and analysis 10 (6), 947-955, 2018 | 17 | 2018 |
| Bioanalytical techniques in discrimination between therapeutic and abusive use of drugs in sport R Ventura, X Matabosch, J Segura Bioanalysis 8 (9), 965-980, 2016 | 15 | 2016 |
| Hair and skin sterols in normal mice and those with deficient dehydrosterol reductase (DHCR7), the enzyme associated with Smith-Lemli-Opitz syndrome M Serra, X Matabosch, L Ying, G Watson, C Shackleton The Journal of steroid biochemistry and molecular biology 122 (5), 318-325, 2010 | 15 | 2010 |
| Budesonide use and misuse in sports: elimination profiles of budesonide and metabolites after intranasal, high‐dose inhaled and oral administrations S Coll, N Monfort, X Matabosch, K Papakonstantinou, C Pérez‐Mañá, ... Drug Testing and Analysis 12 (5), 629-636, 2020 | 14 | 2020 |
